Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carlos Vargas

Clinical Cardiac Electrophysiology Corpus Christi, TX Doctor of Osteopathy

NPI 1245763051 CMS profile 5702181

5917 Otoole Dr, Ste 120, Corpus Christi, TX 78413

Open in the dashboard

General payments

$41,549

278 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$169 paid to institutions, not to them · program year 2019

Through program year 2025, Carlos Vargas of Corpus Christi, TX is reported in the CMS Open Payments database as having received $41,549 across 278 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $169 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 71st percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,453 83
2024 General $18,315 87
2023 General $12,268 36
2022 General $794 24
2021 General $929 34
2020 General $184 6
2019 General $605 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carlos Vargas
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Carlos Vargas were reported at $8,453. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Carlos Vargas Clinical Cardiac Electrophysiology median Middle half National median
2019 $605 $2,361 $585–$8,260 $163
2020 $184 $993 $247–$4,351 $114
2021 $929 $1,185 $326–$4,739 $132
2022 $794 $2,073 $554–$6,789 $149
2023 $12,268 $2,568 $759–$8,159 $160
2024 $18,315 $2,557 $703–$7,403 $164
2025 $8,453 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $12,288 82 payments
  2. Medtronic, Inc. $11,130 67 payments
  3. Abbott Laboratories $9,597 29 payments
  4. Medical Device Business Services, Inc. $4,925 24 payments
  5. Biosense Webster, Inc. $946 18 payments
  6. Janssen Pharmaceuticals, Inc $631 9 payments
  7. Philips Electronics North America Corporation $380 3 payments
  8. Abiomed $197 5 payments
  9. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $170 3 payments
  10. Novartis Pharmaceuticals Corporation $164 10 payments
  11. Other $1,122 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $23,667 9 payments
  2. Food and Beverage $7,611 225 payments
  3. Travel and Lodging $7,600 29 payments
  4. Education $2,671 15 payments
Products named General payments · program years 2019–2025
  1. Carto 3 $5,763 40 payments
  2. Micra $2,246 21 payments
  3. EVERA MRI XT DR SURESCAN $1,557 9 payments
  4. ENSITE $727 3 payments
  5. AURORA EV-ICD MRI SURESCAN $710 11 payments
  6. XARELTO $422 8 payments
  7. INVOKANA $354 3 payments
  8. RESONATE EL ICD VR $275 7 payments
  9. General - EP $225 5 payments
  10. Laser Parts Other $222 2 payments
  11. Other $3,591 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

110

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$16,358

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

27.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 17 $14,966
Flecainide Acetate Generic 17 $660
Metoprolol Succinate Generic 26 $362
Pantoprazole Sodium Generic 21 $151
Doxycycline Monohydrate Generic 16 $140
Clopidogrel Clopidogrel Bisulfate Brand 13 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Records

278 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record